باب
Fluvoxamine
رقم CAS
88699-84-7
الصيغة الجزيئية
C₁₃H₁₆F₃NO₂
وزن جزيئي
275.27 g/mol
مرادف

(E)-N-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]hydroxylamine; (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one oxime; (1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone oxime; Fluvoxamine oxime; (1E)-N-Hydroxy-5-methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanimine Fluvoxamine Oxime Impurity

الكلمات الرئيسية
Metabolites.
Intermediates
Impurities
Pharmaceutical Standards
Fine Chemicals
slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Fluvoxamine EP Impurity I is a structurally related compound that can occur during the manufacture or degradation of fluvoxamine. It is assessed as part of impurity profiling to confirm the quality and purity of the drug substance. Regular monitoring and control of this impurity help ensure that fluvoxamine meets established pharmaceutical quality and regulatory requirements.